Induction of DNA synthesis and apoptosis are separable functions of E2F- 1

Genes and Development

Volumn 11, Issue 14, 1997, Pages 1853-1863

  Phillips, Andrew C ^a   Bates, Stewart ^a   Ryan, Kevin M ^a   Helin, Kristian ^b   Vousden, Karen H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Apoptosis; Cell cycle; E2F; p53

Indexed keywords

TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; DNA SYNTHESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; TUMOR SUPPRESSOR GENE;

EID: 0030739355     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.14.1853     Document Type: Article

References (49)

1. Adams, P.D. and W.G. Kaelin. 1995. Transcriptional control by E2F. Semin. Cancer Biol. 6: 99-108.
2. Almasan, A., Y. Yin, R.E. Kelly, E.Y.-H.P. Lee, A. Bradley, W. Li, J.R. Bertino, and G.M. Wahl. 1995. Deficiency of retinohlastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. 92: 5436-5440.
3. Berry, D.E., Y. Lu, B. Schmidt, P.G. Fallon, C. O'Connell, S.-X. Hu, H.-J. Xu, and G. Blanck. 1996. Retinoblastoma protein inhibits IFN-γ induced apoptosis. Oncogene 12: 1809-1819.
4. Chen, X., L.J. Ko, L. Jayaraman, and C. Prives. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes & Dev. 10:2438-2451.
5. Crook, T., C. Fisher, P.J. Masterson, and K.H. Vousden. 1994a. Modulation of transcriptional regulatory properties of p53 by HPV E6. Oncogene 9: 1225-1230.
6. Crook, T., N.J. Marston, E.A. Sara, and K.H. Vousden. 1994b. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79: 817-827.
7. Field, S.J., F.-Y. Tsai, F. Kuo, A.M. Zubiaga, W.G. Kaelin, D.M. Livingston, S.H. Orkin, and M.E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561.
8. Haas-Kogan, D.A., S.C. Kogan, D. Levi, P. Dazin, A. Tang, Y.K.T. Fung, and M.A. Israel. 1995. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14: 461-472.
9. Harrington, E.A., M.R. Bennett, A. Fanidi, and G.I. Evan. 1994. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13: 3286-3295.
10. Hartwell, L.H. and M.B. Kastan. 1994. Cell cycle control and cancer. Science 266: 1821-1828.
11. Helin, K. and E. Harlow. 1994. Heterodimerization of the transcription factors E2F-1 and DP-I is required for binding to the adenovirus E4 (ORF6/7) protein, J. Virol. 68: 5027-5035.
12. Helin, K., C. Wu, A. Fattaey, J. Lees, B. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes & Dev. 6: 177-185.
13. Hoffmann, F., F. Martelli, D.M. Livingston, and Z. Wang. 1996. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes & Dev. 10: 2949-2959.
14. Johnson, D.G., J.K. Schwarz, J.D. Cress, and J.R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349-352.
15. Johnson, D.G., D. Ohtani, and J.R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes & Dev. 8: 1514-1525.
16. Kaelin, W.G., Jr., W. Krek, W.R. Sellers, J.A. DeCaprio, F. Ajchenbaum, C.S. Fuchs, T. Chittenden, Y. Li, P.J. Farnham, M.A. Blanar, D.M. Livingston, and E.K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastomabinding protein with E2F-like properties. Cell 70: 351-364.
17. Kowalik, T.F., J. Degregori, J.K. Schwarz, and J.R. Nevins. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69: 2491-2500.
18. Krek, W., M.E. Ewen, S. Shirodkar, Z. Arany, W.G. Kaelin, and D.M. Livingston. 1994. Negative regulation of the growthpromoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161-172.
19. Krek, W., G. Xu, and D.M. Livingston. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S-phase checkpoint. Cell 83: 1149-1158.
20. Lam, E.W.F. and R.J. Waston. 1993. An E2F-binding site mediates cell-cycle regulation repression of mouse B-myb transcription. EMBO J. 12: 2705-2713.
21. Lam, E.W.F., J.D.H. Morris, R. Davies, T. Crook, R.J. Waston, and K.H. Vousden. 1994. HPV16 E7 oncoprotein deregulates b-myb expression - correlation with targeting of p107/E2F complexes. EMBO J. 13: 871-878.
22. LaThangue, N.B. 1994. DRTF1/E2F - an expanding family of heterodimeric transcription factors implicated in cell-cycle control Trends Biochem. Sci. 19: 108-114.
23. INK4A-mediated growth suppression. Mol. Cell. Biol. 16: 1047-1057.
24. Macleod, K.F., Y. Hu, and T. Jacks. 1996. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15: 6178-6188.
25. Melillo, R.M., K. Helin, D.R. Lowy, and J.T. Schiller. 1994. Positive and negative regulation of cell proliferation by E2F-1: Influence of protein level and human papillomavirus oncoproteins. Mol Cell. Biol. 14: 8241-8249.
26. Morgenbesser, S.D., B.O. Williams, T. Jacks, and R.A. Depinho. 1994. p53-dependent apoptisis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72-74.
27. Neuman, E., E.K. Flemington, W.R. Sellers, and W.G. Kaelin. 1994. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell. Biol. 14:6607-6615.
28. Ohtani, K., J. DeGregori, and J.R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. 92: 12146-12150.
29. Packham, G., C. Porter, and J.L. Cleveland. 1996. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 13: 461-469.
30. Pan, H.C. and A.E. Griep. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development. Genes & Dev. 8: 1285-1299.
31. Qin, X.-Q., D.M. Livingston, W.G. Kaelin, and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-10922.
32. Qin, X.-Q., D.M. Livingston, M. Ewen, W.R. Sellers, Z. Arany, and W.G. Kaelin. 1995. The transcription factor E2F-1 is a downstream target of RB action. Mol Cell. Biol. 15: 742-755.
33. Rowan, S., R.L. Ludwig, Y. Haupt, S. Bates, X. Lu, M. Oren, and K.H. Vousden. 1996. Specific loss of apoptotic but not cell cycle arrest function in a human tumour derived p53 mutant. EMBO J. 15: 827-838.
34. Rudolph, B., R. Saffrich, J. Zwicker, B, Henglein, R. Müller, W. Ansorge, and M. Eilers. 1996. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis, EMBO J. 15: 3065-3076.
35. Schulze, A., K. Zerfass, D. Spitkovsky, S. Middendorp, J. Berges, K. Helin, P. Jansen-Dürr, and B. Henglein. 1995. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl Acad. Sci. 92: 11264-11268.
36. Sellers, W.R., J.W. Rodgers, and W.G. Kaelin. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. 92: 11544-11548.
37. Shan, B. and W.H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell. Biol. 14:8166-8173.
38. Sherr, C.J. 1996. Cancer cell cycles. Science 274: 1672-1677.
39. Slansky, J.E., Y. Li, W.G. Kaelin, and P.J. Farnham. 1993. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the DHFR promoter. mol. Cell. Biol. 13: 1610-1618.
40. Vojtesek, B., J. Bartek. C.A. Midgley, and D.P. Lane. 1992. An immunochemical analysis of the human nuclear phosphoprotein p53. J. Immunol. Methods 151: 237-244.
41. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
42. Weintraub, S.J., C.A. Prater, and D.C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259-261.
43. Weintraub, S.J., K.N.B. Chow, R.X. Luo, S.H. Zhang, S. He, and D.C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815.
44. Wu, C.-L., L.R. Zukerberg, C. Ngwu, E. Harlow, and J.A. Lees. 1995. In vivo association of E2F and DP family proteins. Mol Cell. Biol 15: 2536-2546.
45. Wu, C.-L., M. Classon, N. Dyson, and E. Harlow. 1996. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in Gl. Mol. Cell Biol 16:3698-3706.
46. Wu, X.W. and A.J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. 91: 3602-3606.
47. Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and N. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548.
48. Zamanian, M. and N.B. La Thangue. 1992. Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J. 11: 2603-2610.
49. Zhu, L., S. Vandenheuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p 107, a relative of the retinoblastoma protein. Genes & Dev. 7: 1111-1125.